Vivien YUI is the Co-Head of the Employment Practice and is a Partner in the Mergers & Acquisitions, Business Establishment, Corporate Governance & Compliance, Health Sciences & Biotechnology, Professional Services and Philippines Practices. Her main practice areas are private mergers and acquisitions, employment, corporate governance and compliance and general corporate and commercial work.
Vivien practises general corporate law, with an emphasis on representing private equity investments, especially in biotechnology and biomedical companies. As the Joint Head of the Firm's Employment Practice, she regularly advises multinational corporations on their global share incentive plans and establishment of local employment practices, benefits and policies. She also assists clients with immigration law and regulatory issues.
Vivien periodically tutors the Advanced Corporate Practice of the preparatory course leading to Part B of the Singapore Bar Examinations run by the Singapore Institute of Legal Education.
Vivien graduated from the National University of Singapore and is admitted to the Singapore Bar.
Significant transactions that Vivien has been involved in include advising / acting for the following:
- GlaxoSmithKline plc ("GSK"), as Singapore counsel, on corporate/commercial and employment matters in relation to GSK's three-part transaction with Novartis International AG ("Novartis") pursuant to which GSK acquired Novartis's global vaccines business (excluding influenza vaccines) for an initial cash consideration of US$5.25 billion. The deal was one of the winning deals in Asian-Mena Counsel Deals of the Year, 2015.
- ESR Funds Management (S) Limited (the manager of ESR-REIT), in the merger with Viva Industrial Trust by way of a trust scheme of arrangement. The merger values Viva Industrial Trust at S$936.7 million and creates Singapore's fourth largest industrial REIT with approximately S$3 billion in property assets. This deal won Best Singapore Deal at the FinanceAsia Awards 2018 and M&A Deal of the Year (Midsize) at the ALB SE Asia Law Awards, 2019.
- Clearbridge Health Limited ("CBH") in the acquisition of 49% of the issued and paid-up share capital of PT Tirta Medika Jaya ("TMJ") by Clearbridge Medical Asia Pte. Ltd., an indirect wholly-owned subsidiary of CBH, from Ark Investments (SG) Pte. Ltd. In connection with the Acquisition, CBMA also subscribed for an exchangeable bond issued by PT Genesis Kapital Investama, one of the shareholders of TMJ.
- Clearbridge BioMedics Pte. Ltd. in its S$6.6 million pre-IPO financing and the consolidation of its capital structure by converting all preferred shares and convertible securities to ordinary shares of Clearbridge BioMedics in preparation for the potential IPO.
- EFG BANK AG, Singapore Branch in the acquisition of BSI Bank Limited's Singapore private banking business. This follows the announcement on 22 February 2016 by EFG International and BSI Bank that EFG International will acquire BSI Bank to form one of the largest private banks in Switzerland with approximately CHF 170 billion in assets under management, for a purchase price of approximately CHF 1,328 million.
- Skyworks Solutions, Inc., in the labour and work visa matters in relation to its joint venture with Panasonic Corporation to design, develop and deliver high performance filters, including surface acoustic wave ("SAW") devices and temperature compensated SAW devices ("TC-SAW") and the acquisition by the joint venture of Panasonic Corporation's SAW and TC-SAW business in Singapore.
Related Practices
- Business Establishment
- Corporate Governance & Compliance
- Employment
- Health Sciences & Biotechnology
- Mergers & Acquisitions
- Philippines
- Professional Services
- The Legal 500: Country Comparative Guides – Singapore – Employee Incentives, 2024
- Thomson Reuters Practical Law Employee Share Plans Global Guide 2024 - Singapore Chapter
- LegisWatch: New Tripartite Guidelines on Flexible Work Arrangement Requests Effective December 2024
- LegisWatch: SGX RegCo Requires Large Issuers to Take Lead to Reduce AGM Crunch, Reserve AGM Slots in Advance
- LegisWatch: Changes to Mandatory Training Requirement for First-time Directors of SGX-listed Issuers
- LegisWatch: Changes to Conduct of Meetings: Companies, Business Trusts and Other Bodies (Miscellaneous Amendments) Act 2023 and Listing Manual Practice Notes on General Meetings
- LegisWatch: Changes to the Global Investor Programme
- LegisWatch: Changes to Listing Rules: Tenure of Independent Directors Capped at Nine Years; Remuneration of Directors and CEOs Must Be Disclosed
- LegisWatch: Budget 2023 – Employment Updates
- LegisWatch: Enhanced Tripartite Guidelines on Exercising Sensitivity for Harmonious Workplace
Vivien is recommended as a leading practitioner for Employment in Best Lawyers; Asialaw Profiles – The Guide to Asia-Pacific's Leading Domestic Law Firms; The Legal 500: Asia Pacific – The Guide to Asia's Commercial Law Firms and in Chambers Asia-Pacific – Asia-Pacific's Leading Lawyers for Business.
Vivien is recognised as a leading lawyer in the area of Life Sciences – transactional in Who's Who Legal's The International Who's Who of Life Sciences Lawyers and The International Who's Who of Business Lawyers and in the area of M&A and Corporate Governance in Who's Who Legal's The International Who's Who of M&A and Corporate Governance Lawyers.
For her work in employment Vivien has been praised in The Legal 500 as "very practical", "knowledgeable" and "responsive to clients’ needs". In Asialaw Profiles a client provided feedback that “Vivien’s bedside manner is unparalleled. Her commercial acumen from years in capital markets work also uniquely places her amongst the top regulatory and compliance lawyers”. The client also noted that “She is our conscience at times, which tells you how much trust we have in her judgement and advice”.
Contact Details
- d+65 6416 8009
- f+65 6532 5711
- evivien.yui@wongpartnership.com
Career & Qualifications
National University of Singapore (LL.B., Hons.)